News
Upcoming Events
3rd Annual International Symposium on Magnetic Gastrointestinal and Colon Surgery
Led by MagDI™ System inventor Michel Gagner, MD, you’re invited to join your peers from around the globe and experience the latest advancements in technology and tools for magnetic surgical techniques. This world-class program will include:
- Live surgery broadcasts – Observe live procedures including small bowel and sleeve gastrectomy using MagDI™ System magnets
- Expert faculty – Join renowned presenters from North America, Latin America, Europe and Asia Pacific
- Comprehensive discussions – Explore techniques, results, indications, contraindications and complications management, and for in-person attendees, insights from an ASMBS panel
The Symposium will be hosted at the Fairmont Queen Elizabeth Hotel, Montreal, Quebec, Canada on May 30th and 31st.
Press Releases
GT Metabolic™ Expands MagDI™ System with FDA-cleared 50mm Magnet
Minneapolis, MN – March 11, 2025 – GT Metabolic™ Solutions, Inc., the world leader in magnetic surgery is pleased to announce that the FDA has cleared a larger, 50mm MagDI™ System magnet to complement the system’s existing 40mm magnet.
Read More
GT Metabolic™ Solutions, Inc., announces completion of the first magnetic compression anastomosis cases in the USA
Minneapolis, MN – November 19, 2024 – GT Metabolic™ Solutions, Inc. is pleased to announce the completion of the first magnetic compression anastomosis cases in the U.S. Helmuth Billy, MD, of Ventura Advanced Surgical Associates in Ventura, CA, completed the cases using the MagDI™ System.
Read More
FDA clearance issued for revolutionary magnetic compression surgical technique soon to launch in U.S. market
Minneapolis, MN – October 29, 2024 – GT Metabolic™ Solutions Inc., the global leader in magnetic compression anastomosis surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared GT Metabolic’s MagDI™ System for side-to-side duodeno-ileal (DI) anastomosis.
Read More
GT Metabolic™ Solutions, Inc., opens doors to new surgical platform as FDA grants De Novo marketing authorization to its novel magnet compression anastomosis technology
Minneapolis, MN – September 4, 2024 – GT Metabolic™ Solutions, Inc., a company dedicated to reinventing bariatric, metabolic, and digestive surgery, today announced its first-generation MagDI™ System for side-to-side duodeno-ileal anastomosis was granted De Novo marketing authorization from the U.S. Food and Drug Administration (FDA).
Read More
Stories
AIS Channel, May 2023
87th IBC – University of Oxford Surgery Webinar, April 2023
MSGR Webinar, November 2023
IBC-TV Interview with Prof. Michel Gagner